Kim Yong Sang, Oh Sun Mi, Suh Dong Suk, Tak Dae Hyun, Kwon Yoo Beom, Koh Yong Gon
Center for Stem Cell & Arthritis Research, Department of Orthopaedic Surgery, Yonsei Sarang Hospital, 10, Hyoryeong-Ro, Seocho-Gu, Seoul, 06698, Republic of Korea.
J Exp Orthop. 2023 Mar 15;10(1):28. doi: 10.1186/s40634-023-00592-1.
This study evaluated outcomes in patients with knee osteoarthritis following stromal vascular fraction implantation and assessed the associated prognostic factors.
We retrospectively evaluated 43 patients who underwent follow-up magnetic resonance imaging 12 months after stromal vascular fraction implantation for knee osteoarthritis. Pain was assessed using the visual analogue scale and measured at baseline and 1-, 3-, 6-, and 12-month follow-up appointments. In addition, cartilage repair was evaluated based on the Magnetic Resonance Observation of Cartilage Repair Tissue scoring system using the magnetic resonance imaging from the 12-month follow-up. Finally, we evaluated the effects of various factors on outcomes following stromal vascular fraction implantation.
Compared to the baseline value, the mean visual analogue scale score significantly and progressively decreased until 12 months post-treatment (P < 0.05 for all, except n.s. between the 1 and 3-month follow-ups). The mean Magnetic Resonance Observation of Cartilage Repair Tissue score was 70.5 ± 11.1. Furthermore, the mean visual analogue scale and Magnetic Resonance Observation of Cartilage Repair Tissue scores significantly correlated 12 months postoperatively (P = 0.002). Additionally, the cartilage lesion size and the number of stromal vascular fraction cells significantly correlated with the 12-month visual analogue scale scores and the Magnetic Resonance Observation of Cartilage Repair Tissue score. Multivariate analyses determined that the cartilage lesion size and the number of stromal vascular fraction cells had a high prognostic significance for unsatisfactory outcomes.
Stromal vascular fraction implantation improved pain and cartilage regeneration for patients with knee osteoarthritis. The cartilage lesion size and the number of stromal vascular fraction cells significantly influenced the postoperative outcomes. Thus, these findings may serve as a basis for preoperative surgical decisions.
IV.
本研究评估了基质血管成分植入术后膝骨关节炎患者的预后,并评估了相关的预后因素。
我们回顾性评估了43例因膝骨关节炎接受基质血管成分植入术后12个月接受随访磁共振成像检查的患者。使用视觉模拟量表评估疼痛,并在基线以及1、3、6和12个月的随访预约时进行测量。此外,使用12个月随访的磁共振成像,基于软骨修复组织的磁共振观察评分系统评估软骨修复情况。最后,我们评估了各种因素对基质血管成分植入术后预后的影响。
与基线值相比,平均视觉模拟量表评分在治疗后12个月前显著且逐渐降低(除1个月和3个月随访之间无统计学差异外,所有比较P均<0.05)。软骨修复组织的磁共振观察平均评分为70.5±11.1。此外,术后12个月时平均视觉模拟量表评分与软骨修复组织的磁共振观察评分显著相关(P = 0.002)。此外,软骨损伤大小和基质血管成分细胞数量与12个月时的视觉模拟量表评分以及软骨修复组织的磁共振观察评分显著相关。多因素分析确定,软骨损伤大小和基质血管成分细胞数量对预后不良具有较高的预后意义。
基质血管成分植入改善了膝骨关节炎患者的疼痛和软骨再生。软骨损伤大小和基质血管成分细胞数量显著影响术后预后。因此,这些发现可为术前手术决策提供依据。
IV级